Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Frontage Appoints CEO and President | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Frontage Appoints CEO and President

Dr. Abdul Mutlib succeeds founder Dr. Song Li as CEO, Dr. John Lin has been promoted to President.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Frontage Holdings Corp. has promoted Dr. Abdul Mutlib to Chief Executive Officer, succeeding Frontage’s founder Dr. Song Li, who will remain as Executive Chairman of the Board of Directors.  Dr. John Lin has been promoted to President of Frontage Laboratories, Inc., the company’s wholly-owned subsidiary. As Executive Chairman, Dr. Li will continue to actively participate in the leadership of the company and focus on strategic growth opportunities.
 
Dr. Mutlib has been a member of Frontage’s executive team for more than 12 years, where he has overseen the company’s Preclinical (DMPK/Safety and Toxicology) business.  Dr. Lin has been an executive with Frontage for more than 15 years, responsible for building and leading the company’s extensive Bioanalytical and Biologics service capabilities.
 
Dr. Li said, “The promotions announced today are intended to optimize the leadership structure of the company both to reflect our current size as a global organization with over 1600 employees across 24 sites and to position us for further growth as we move into the future.  Abdul and John are proven leaders who have delivered phenomenal results for Frontage for over a decade, and they are each trusted and respected throughout the organization and pharmaceutical industry.  We have been preparing them for their new responsibilities for some time and Frontage is privileged to elevate them to their new roles.  This is an exciting time for Frontage, and I am looking forward to maintaining my close working relationship with Abdul and John as we continue to serve our stakeholders worldwide.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters